By Developing new medications is an arduous and expensive journey, with fewer than 10% of drug candidates making it to market. To enhance efficiency and accessibility in drug development, the industry is increasingly turning to advancements in data analytics and artificial intelligence (AI).
Breakthroughs in fields such as life sciences, robotics, and computational technology have significantly accelerated progress in the pharmaceutical sector. By harnessing vast datasets and AI-driven tools, researchers are uncovering fresh avenues for drug innovation. But in what ways are AI and big data actually propelling advancements in drug discovery?
AI and big data play a vital role in pinpointing promising drug candidates and evaluating their commercial potential. Machine learning, in particular, allows for rapid analysis of extensive datasets, improving decision-making and expediting the creation of new treatments. Additionally, animal models like transgenic rats have become increasingly valuable in unveiling new therapies and advancing research efforts.
Although drug development requires significant investment, the pharmaceutical industry is set for robust growth. Forecasts indicate the market could hit $71 billion by 2025, driven largely by AI, big data, and other emerging technologies transforming healthcare and drug discovery.
For a more in-depth look into the drug development process and the trends shaping its future, explore the comprehensive resource below.
